Profusa (PFSA) Short-Term Debt issuances (2025 - 2026)

Profusa (PFSA) reported Short-Term Debt issuances of $469000.0 for Q1 2026, down 93.04% quarter-over-quarter from $6.7 million in Q4 2025.

Profusa (PFSA) Short-Term Debt issuances (2025 - 2026) Analysis & Trends

Profusa has reported Short-Term Debt issuances for 2 years, with the latest figure at $469000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ST Debt Issuance (Qtr)
1	Abbott Laboratories	157.80 Bn	151.14 Bn	6.27 Bn	31.00 Mn
2	Stryker	115.54 Bn	112.66 Bn	3.81 Bn	-
3	Medtronic	103.44 Bn	95.27 Bn	5.76 Bn	-1.23 Bn
4	Boston Scientific	72.38 Bn	71.17 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.76 Bn	46.09 Bn	1.29 Bn	-
6	Dexcom	29.53 Bn	28.42 Bn	750.30 Mn	-
7	GE HealthCare Technologies	29.51 Bn	27.44 Bn	1.98 Bn	-1.00 Mn
8	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	12.88 Mn
9	Steris	20.69 Bn	20.27 Bn	697.10 Mn	37.80 Mn
10	Profusa	2.14 Mn	2.14 Mn	-	469,000.00

Download Data